Cholesterol, inflammation and innate immunity - Wikidata - awgldk - TriplyDB

Cholesterol, inflammation and innate immunity

Cholesterol, inflammation and innate immunity

http://www.wikidata.org/entity/Q28086912

about

Is the risk of cardiovascular disease altered with anti-inflammatory therapies? Insights from rheumatoid arthritis Exploring the Homeostatic and Sensory Roles of the Immune System Liver immunology and its role in inflammation and homeostasis Caveolae and Caveolin-1 Integrate Reverse Cholesterol Transport and Inflammation in Atherosclerosis Innovative Target Therapies Are Able to Block the Inflammation Associated with Dysfunction of the Cholesterol Biosynthesis Pathway Inflammation as a Keystone of Bone Marrow Stroma Alterations in Primary Myelofibrosis "TRP inflammation" relationship in cardiovascular system Is higher serum cholesterol associated with altered tendon structure or tendon pain? A systematic review Bioactive Egg Components and Inflammation Breast Milk and Solid Food Shaping Intestinal Immunity Metabolic Flexibility and Dysfunction in Cardiovascular Cells Exploiting genomics and natural genetic variation to decode macrophage enhancers Prolonged sleep restriction induces changes in pathways involved in cholesterol metabolism and inflammatory responses.Pathophysiology of Non Alcoholic Fatty Liver Disease Molecular Pathogenesis of NASH Multi-walled carbon nanotube induces nitrative DNA damage in human lung epithelial cells via HMGB1-RAGE interaction and Toll-like receptor 9 activation Immune cell screening of a nanoparticle library improves atherosclerosis therapy Mitochondrial Control of Innate Immunity and Inflammation Expression profiles of cholesterol metabolism-related genes are altered during development of experimental autoimmune encephalomyelitis in the rat spinal cord.Hyaluronan Nanoparticles Selectively Target Plaque-Associated Macrophages and Improve Plaque Stability in Atherosclerosis Treatment of HIV infection with a raltegravir-based regimen increases LDL levels, but improves HDL cholesterol efflux capacity.Cyclodextrin promotes atherosclerosis regression via macrophage reprogramming.Genotype-Dependent Effects of Dalcetrapib on Cholesterol Efflux and Inflammation: Concordance With Clinical Outcomes Proinflammatory Stimulation of Toll-Like Receptor 9 with High Dose CpG ODN 1826 Impairs Endothelial Regeneration and Promotes Atherosclerosis in Mice.Scavenger receptor class B, type I-mediated uptake of A1AT by pulmonary endothelial cells Plasma High-Mannose and Complex/Hybrid N-Glycans Are Associated with Hypercholesterolemia in Humans and Rabbits.Lipidomic Profiling of Adipose Tissue Reveals an Inflammatory Signature in Cancer-Related and Primary Lymphedema.Macrophage Phenotype and Function in Different Stages of Atherosclerosis.Disruption of Glut1 in Hematopoietic Stem Cells Prevents Myelopoiesis and Enhanced Glucose Flux in Atheromatous Plaques of ApoE(-/-) Mice.Retinol-binding protein 4 and its potential roles in hypercholesterolemia revealed by proteomics Clofazimine Biocrystal Accumulation in Macrophages Upregulates Interleukin 1 Receptor Antagonist Production To Induce a Systemic Anti-Inflammatory State Systematic analysis of the molecular mechanism underlying atherosclerosis using a text mining approach Cardiovascular Risk Factors and Ischemic Heart Disease: Is the Confluence of Risk Factors Greater Than the Parts? A Genetic Approach.Postmenopausal Women Have Higher HDL and Decreased Incidence of Low HDL than Premenopausal Women with Metabolic Syndrome.Local TNF causes NFATc1-dependent cholesterol-mediated podocyte injury.Enhanced HDL Functionality in Small HDL Species Produced Upon Remodeling of HDL by Reconstituted HDL, CSL112: Effects on Cholesterol Efflux, Anti-Inflammatory and Antioxidative Activity.The relationship between non-HDL cholesterol and macrophage phenotypes in human adipose tissue.Activation and increase of radio-sensitive CD11b+ recruited Kupffer cells/macrophages in diet-induced steatohepatitis in FGF5 deficient mice.TREM-1 links dyslipidemia to inflammation and lipid deposition in atherosclerosis.Analysis of CH25H in multiple sclerosis and neuromyelitis optica.

P2860

Q26746659-68C658E5-AC63-43AF-8990-598061C8763D Q26750366-C743AE6D-52E6-460B-BD17-F9D00D5AA574 Q26750478-FAE49E37-9014-4A55-90AC-6A4361B8832C Q26752101-DE87E694-6AB8-43CC-AA63-62B0F5E8116E Q26771260-8CB84133-67D9-4741-B758-72580817B8A2 Q26774212-177CC2B2-CA71-4D35-ACB8-2B0A6AED3025 Q26781720-B3F9A00A-59B3-4666-ADB7-39EC37816D33 Q26782221-21A5EC18-B830-442E-B250-F1323EB8BCF9 Q26782731-93A934DF-2F1D-49C9-B56B-3BC4627CD86D Q26782801-10E16C8E-C3FF-403B-A229-E17B3B9F2BE0 Q26796679-1F54771F-0094-497A-BBC7-97F849376A84 Q26825066-9EE318E5-91FC-4DB8-BB8B-312B0A1DF837 Q27319844-F07F19D1-68EE-4CC9-A396-28F35644D14A Q28070011-D0BF3045-1B5E-444F-9F27-CCFC16A8B4A4 Q28071265-A35D4C4A-4BED-4DAF-81AD-394D5A4B534B Q28390894-39C40D67-C981-4DA7-BA11-5B6F3A45190F Q28393434-6959DB04-8D3B-449F-A468-8725F8C848D6 Q33611330-C1C7BFC0-557A-403E-B5DC-D12178194AA6 Q33758896-3F5B20E0-98C4-42FC-A0EB-B1CB9260B4C1 Q33856678-A5E867D8-955A-475C-82A2-7A1E768EEAD8 Q33917580-6FF2A3C4-2521-4F80-8855-3E712154E0A3 Q34521175-8CFEED06-B728-4A5B-8B1F-0A62C6886ADD Q34534212-E4799A70-FD60-45CA-BF96-9AC19881DB51 Q35889971-2DDCAFE7-80E3-4CAE-9EF0-D834FF3C9D87 Q35959814-870A003A-216A-4F7F-A8CE-94AD21C30D94 Q35964836-C148E430-B939-4FC1-B41F-0D963BCB0BF9 Q36018490-6306F341-1674-4DFF-AC64-BF08AA38586B Q36602809-BEF9AF4F-17DD-4656-A337-9BA455CAAEAA Q36776429-8CF66A92-F041-4DA1-AC70-CA1BD46565B9 Q36806825-8A7423EE-A19F-4900-BF00-53988639DBD8 Q36933396-427EA8B6-C0FD-4C0E-BE0A-838F6AF38316 Q36960706-0155E5A4-9A89-48AC-AAD5-0333C0ABFFBC Q37029760-1432AE73-F39F-46F0-A797-7A7CCDEA34E7 Q37069367-978C439E-0925-4C2C-84D0-8134C16C34DC Q37217446-EA668898-9D24-4F1A-B89A-4B18590867D6 Q37221857-A9FB76ED-9BEF-461E-AF5A-5BB453FB4F1D Q37282876-192D8F0E-83D0-4AA0-AD41-FC263DE0F615 Q37314995-BEC67471-C02F-4E91-8986-C7B358E12A95 Q37366497-07BDC056-636C-4192-ADF4-665D2A3691A7 Q37388829-1559F100-0DBC-435E-82F9-4BE8D9943891

P2860

Cholesterol, inflammation and innate immunity

http://www.wikidata.org/entity/Q28086912

description

2015 nî lūn-bûn

@nan

2015 թուականի Փետրուարին հրատարակուած գիտական յօդուած

@hyw

2015 թվականի փետրվարին հրատարակված գիտական հոդված

@hy

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

name

Cholesterol, inflammation and innate immunity

@ast

Cholesterol, inflammation and innate immunity

@en

Cholesterol, inflammation and innate immunity

@nl

type

label

Cholesterol, inflammation and innate immunity

@ast

Cholesterol, inflammation and innate immunity

@en

Cholesterol, inflammation and innate immunity

@nl

prefLabel

Cholesterol, inflammation and innate immunity

@ast

Cholesterol, inflammation and innate immunity

@en

Cholesterol, inflammation and innate immunity

@nl

P1433

Q28086912-8033FA6D-580C-4C46-899A-6B5AF0C5BC4A

P1476

Q28086912-CDEAD829-F79C-48C2-92BF-1B9B447E53CE

P2093

Q28086912-30E70128-AA8A-42D6-B1E4-E364E86CB861

P2860

Q28086912-001E87B4-C923-427F-9DC0-13CF56DDA853

Q28086912-010E9A66-08AC-4AC0-8741-B08A8C94179B

Q28086912-02647258-9537-404A-95F5-06AF7E78F88D

Q28086912-034C89EE-B0D2-4D90-8A23-57C9404B876D

Q28086912-04E52FEF-2AC4-4844-8DF1-346B9E55EA04

Q28086912-052B2C74-07E5-4090-B820-A1F8DE2235DF

Q28086912-0568A831-E90B-4E45-BA03-0F1870B9B4CF

Q28086912-084EFF4A-5F46-4E7E-A9CB-18633B283234

Q28086912-0A5064FB-5A40-42C8-818B-AEB155806DB0

Q28086912-0AF5F839-9D5A-4268-8C7F-70F467B8BCBD

P2888

Q28086912-B6599869-7690-4D20-9C7F-F95FAC84935E

P304

Q28086912-BA93582E-F7C3-4762-AED0-99A968052988

P31

Q28086912-7BE9CD67-C3E3-42DB-B6EF-24F4FB9DCA00

P3181

Q28086912-87FABEB8-FFF4-405D-9A96-031FEAE0F367

P356

Q28086912-EEF3862E-E598-4E06-AD59-3D274A6CD13B

P407

Q28086912-264839DF-0DA6-4C18-BDFC-C402179FE6CF

P433

Q28086912-F1BFA677-2905-4BB4-A7DB-701B3C0B28D9

P478

Q28086912-64EF82B7-4839-4182-A3C3-F5E9FF41B8ED

P50

Q28086912-036320F0-08DD-4BDA-8F10-C307A5E24895

P577

Q28086912-17C21649-E6F7-4907-9699-40E7FB7B20E9

P6179

Q28086912-F83D7B64-D17B-4C72-81BC-3CAF0AFA573F

P698

Q28086912-47164218-D752-4290-B934-6626838CD92C

P921

Q28086912-93895D65-AA5E-489F-A429-B1FCF62BDA6D

P932

Q28086912-429C29DD-6DB8-41A6-BB42-0D90074CE31D

P3181

P356

P1433

Nature Reviews Immunology

P1476

Cholesterol, inflammation and innate immunity

@en

P2093

Alan R Tall

http://www.w3.org/2001/XMLSchema#string

P2860

RVX-208, an inducer of ApoA-I in humans, is a BET bromodomain antagonist

Activation of autophagy by inflammatory signals limits IL-1β production by targeting ubiquitinated inflammasomes for destruction

Overexpression of ABCG5 and ABCG8 promotes biliary cholesterol secretion and reduces fractional absorption of dietary cholesterol

Oxysterols direct immune cell migration via EBI2

LXRs control lipid-inducible expression of the apolipoprotein E gene in macrophages and adipocytes

Regulated accumulation of desmosterol integrates macrophage lipid metabolism and inflammatory responses

CD36 ligands promote sterile inflammation through assembly of a Toll-like receptor 4 and 6 heterodimer

Identification of splenic reservoir monocytes and their deployment to inflammatory sites

Parallel SUMOylation-dependent pathways mediate gene- and signal-specific transrepression by LXRs and PPARgamma

ATP-binding cassette transporters, atherosclerosis, and inflammation

P2888

P304

104-116

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

1077882

http://www.w3.org/2001/XMLSchema#string

P356

10.1038/NRI3793

http://www.w3.org/2001/XMLSchema#string

P407

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

15

http://www.w3.org/2001/XMLSchema#string

P50

Laurent Yvan-Charvet

P577

2015-02-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1016759517

http://www.w3.org/2001/XMLSchema#string

P698

25614320

http://www.w3.org/2001/XMLSchema#string

P921

P932

4669071

http://www.w3.org/2001/XMLSchema#string